Last reviewed · How we verify

NCT05329207: ASGE-FABES

Effects of Web-Based Adolescent Health Promotion Program in Hearing Impaired Adolescents

Status unknown NA Last updated 14 April 2022
What this trial tests

NA trial testing Experimental group in Health Promotion in 70 participants. Status unknown.

Timeline
18 April 2022
Primary endpoint
18 October 2022
18 November 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment70
Start date18 April 2022
Primary completion18 October 2022
Estimated completion18 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 12 to 18, any sex, with Health Promotion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our research is to evaluate the effect and applicability of the adolescent health promotion program, which includes multiple behavioral interventions, on physical activity, nutrition and mental health of hearing impaired adolescents living in the community.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of web-based cope healthy lifestyles TEEN program on hearing-impaired adolescents: A randomized controlled trial.
    Orakci H, Ardiç A. · · 2026 · PMID 41418421 · DOI 10.1016/j.pedn.2025.12.006

Verify or expand the search:

Other trials of Experimental group

Trials testing the same drug.

Other recruiting trials for Health Promotion

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05329207.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing